CompletedNCT04720001
Florbetaben PET Imaging in PPA
Studying Primary progressive aphasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Chicago
- Principal Investigator
- Emily Rogalski, Ph.DUniversity of Chicago
- Intervention
- Florbetaben F18(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2018 – 2021
Study locations (1)
- University of Chicago - American School Building, Chicago, Illinois, United States
Collaborators
Northwestern University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04720001 on ClinicalTrials.govOther trials for Primary progressive aphasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07219680Intervention for Communication Quality of Life in Primary Progressive AphasiaUniversity of Texas at Austin
- RECRUITINGNANCT07260253Remotely-supervised Neuromodulation in PPAUniversity of Texas at Austin
- RECRUITINGNANCT07158216Long Term Effect of Brain Stimulation in PPAHospital San Carlos, Madrid
- RECRUITINGPHASE2NCT07033481Clinical Study of Neflamapimod in Patients With Primary Progressive AphasiaEIP Pharma Inc
- RECRUITINGNCT06739967Speech and Language Interventions for Italian People With PPAIstituti Clinici Scientifici Maugeri SpA
- RECRUITINGPHASE2NCT06191198Communication Bridge 3 StudyUniversity of Chicago
- ACTIVE NOT RECRUITINGNANCT06211374Communication Bridge Pilot StudyUniversity of Chicago
- RECRUITINGPHASE2NCT05386394Transcranial Direct Current Stimulation in the Treatment of Primary Progressive AphasiaJohns Hopkins University